Drug intelligence / Profile preview

Sound Asleep Gummies

Development stage
Unknown
Lead developer
Medterra
Modality
Small Molecules
Administration
Oral
01

Overview

Sound Asleep Gummies are a consumer wellness product developed by Medterra, designed to support sleep and address insomnia-related concerns. Formulated as a full-spectrum hemp-derived edible, each gummy contains a combination of 5mg delta-9 THC, 50mg CBD, 3mg melatonin, and 100mg L-theanine. The product leverages the 'entourage effect,' where cannabinoids and supplemental ingredients work synergistically to interact with the endocannabinoid system and circadian rhythm regulators. Specifically, THC acts as an agonist at cannabinoid receptors (CB1 and CB2) to promote relaxation, while melatonin serves as an exogenous hormone to signal the sleep-wake cycle by targeting melatonin receptors. L-theanine is included to promote relaxation by modulating neurotransmitters such as glutamate. It is marketed under the 2018 Farm Bill as a hemp-derived product containing less than 0.3% THC by dry weight.

Brand names
Sound AsleepSound Asleep GummiesMedterra Sound Asleep THC Gummies
Other names
Medterra Sound Asleep GummiesSound Asleep-Medterra-THC gummy
02

Targets

MTNR1B (Melatonin Receptor 2)CNR1 (Cannabinoid receptor 1)MTNR1A (MT1)

Beyond the preview

Go deeper on Sound Asleep Gummies.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sound Asleep Gummies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call